Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article Report
  • Published:

Author's response to “Comment on “Does ferric gluconate lower epoetin requirements in hemodialysis patients with high ferritin levels?””

Nature Clinical Practice Nephrology volume 4, page E2 (2008)Cite this article

Access through your institution
Buy or subscribe

Response to: Coyne DW et al. (2008) Comment on “Does ferric gluconate lower epoetin requirements in hemodialysis patients with high ferritin levels?” Nat Clin Pract Nephrol [doi:10.1038/ncpneph0965]

Original article: Agarwal R et al. (2008) Does ferric gluconate lower epoetin requirements in hemodialysis patients with high ferritin levels? Nat Clin Pract Nephrol 4: 418–419

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Holden JE et al. (2008) Analyzing change: a primer on multilevel models with applications to nephrology. Am J Nephrol 28: 792–801

    Article  Google Scholar 

  2. Mallinckrodt CH et al. (2001) Accounting for dropout bias using mixed-effects models. J Biopharm Stat 11: 9–21

    Article  CAS  Google Scholar 

  3. Agarwal R (2008) Iron, oxidative stress, and clinical outcomes. Pediatr Nephrol 23: 1195–1198

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Indiana University School of Medicine, 1481 West 10th Street, 111N, Indianapolis, 46202, IN, USA

    Rajiv Agarwal

Authors
  1. Rajiv Agarwal
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Rajiv Agarwal.

Ethics declarations

Competing interests

The author declared that he serves on the Scientific Advisory Board of Watson Pharmaceuticals, the sponsor of the DRIVE trial.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agarwal, R. Author's response to “Comment on “Does ferric gluconate lower epoetin requirements in hemodialysis patients with high ferritin levels?””. Nat Rev Nephrol 4, E2 (2008). https://doi.org/10.1038/ncpneph0966

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpneph0966

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing